RG
NVS icon

Rikoon Group’s Novartis NVS Stock Holding History

Rikoon Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$1.34M Sell
15,660
-364
-2% -$32.7K 0.36% 63
2020
Q4 		$1.51M Sell
16,024
-73
-0.5% -$6.38K 0.42% 52
2020
Q3 		$1.4M Buy
16,097
+65
+0.4% +$5.63K 0.43% 52
2020
Q2 		$1.4M Buy
16,032
+2,653
+20% +$229K 0.47% 48
2020
Q1 		$1.1M Buy
13,379
+1,957
+17% +$175K 0.46% 54
2019
Q4 		$1.08M Sell
11,422
-210
-2% -$18.8K 0.37% 74
2019
Q3 		$1.01M Hold
11,632
– – 0.37% 73
2019
Q2 		$1.06M Sell
11,632
-2,414
-17% -$204K 0.4% 69
2019
Q1 		$1.21M Sell
14,046
-517
-4% -$41.5K 0.45% 58
2018
Q4 		$1.12M Buy
14,563
+1,228
+9% +$95.6K 0.46% 57
2018
Q3 		$1.03M Sell
13,335
-2,296
-15% -$170K 0.36% 76
2018
Q2 		$1.06M Buy
15,631
+582
+4% +$40.2K 0.4% 67
2018
Q1 		$1.07M Buy
15,049
+104
+0.7% +$7.92K 0.43% 60
2017
Q4 		$1.12M Buy
14,945
+66
+0.4% +$4.98K 0.46% 61
2017
Q3 		$1.15M Hold
14,879
– – 0.5% 55
2017
Q2 		$1.11M Sell
14,879
-809
-5% -$57.3K 0.49% 58
2017
Q1 		$1.08M Buy
15,688
+837
+6% +$55.8K 0.48% 58
2016
Q4 		$1M Buy
14,851
+1,777
+14% +$115K 0.44% 67
2016
Q3 		$925K Buy
+13,074
New +$953K 0.73% 49

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rikoon Group's NVS Position: Q1 2021 in Review

Rikoon Group reduced its Novartis (NVS) stake by 2.3% in Q1 2021, selling an estimated $32.7K and leaving 15,660 shares worth $1.34M. The position accounts for 0.36% of the portfolio, ranked #63.

Rikoon Group first reported a position in NVS in Q3 2016 and has held it in 19 quarters since. The position peaked at $1.51M in Q4 2020. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2021.

  • Rikoon Group held 15,660 shares of Novartis worth $1.34M as of Q1 2021.
  • Rikoon Group sold 364 Novartis shares in Q1 2021, an estimated $32.7K.
  • Novartis made up 0.36% of Rikoon Group's portfolio in Q1 2021, its #63 holding.
  • Rikoon Group first reported a position in Novartis in Q3 2016 and has held it in 19 quarters since.
  • Rikoon Group's Novartis position peaked at $1.51M in Q4 2020.
  • 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.